These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 23932842

  • 1. Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice.
    Barwatt JW, Hofford RS, Emery MA, Bates ML, Wellman PJ, Eitan S.
    Drug Alcohol Depend; 2013 Oct 01; 132(3):420-6. PubMed ID: 23932842
    [Abstract] [Full Text] [Related]

  • 2. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.
    Hofford RS, Wellman PJ, Eitan S.
    J Psychopharmacol; 2012 Oct 01; 26(10):1355-65. PubMed ID: 22522973
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors.
    Emery MA, Bates ML, Wellman PJ, Eitan S.
    Behav Brain Res; 2015 May 01; 284():37-41. PubMed ID: 25617530
    [Abstract] [Full Text] [Related]

  • 4. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
    Brudzynski SM, Komadoski M, St Pierre J.
    Behav Brain Res; 2012 Jan 15; 226(2):511-8. PubMed ID: 22015714
    [Abstract] [Full Text] [Related]

  • 5. Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.
    Chiang YC, Hung TW, Ho IK.
    Addict Biol; 2014 Jul 15; 19(4):676-86. PubMed ID: 23551991
    [Abstract] [Full Text] [Related]

  • 6. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 15; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 7. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
    Sheppard B, Lehmann J, Cope ZA, Brown RW.
    Behav Neurosci; 2009 Dec 15; 123(6):1296-308. PubMed ID: 20001113
    [Abstract] [Full Text] [Related]

  • 8. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.
    Akhisaroglu M, Kurtuncu M, Manev H, Uz T.
    Pharmacol Biochem Behav; 2005 Mar 15; 80(3):371-7. PubMed ID: 15740778
    [Abstract] [Full Text] [Related]

  • 9. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
    Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA.
    Neuropsychopharmacology; 2006 Nov 15; 31(11):2349-58. PubMed ID: 16855533
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov 15; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

  • 11. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
    Perreault ML, Graham D, Bisnaire L, Simms J, Hayton S, Szechtman H.
    Neuropsychopharmacology; 2006 Sep 15; 31(9):1967-81. PubMed ID: 16237381
    [Abstract] [Full Text] [Related]

  • 12. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
    Beerepoot P, Lam V, Luu A, Tsoi B, Siebert D, Szechtman H.
    Neurosci Lett; 2008 Dec 03; 446(2-3):101-4. PubMed ID: 18824069
    [Abstract] [Full Text] [Related]

  • 13. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging.
    Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, Williams SC.
    Neuroscience; 2005 Dec 03; 133(1):315-26. PubMed ID: 15893653
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration.
    Li T, Hou Y, Yan CX, Chen T, Zhao Y, Li SB.
    Neurosci Lett; 2010 Nov 26; 485(3):256-60. PubMed ID: 20849922
    [Abstract] [Full Text] [Related]

  • 15. Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.
    Vorhees CV, Johnson HL, Burns LN, Williams MT.
    Neurotoxicol Teratol; 2009 Nov 26; 31(1):1-10. PubMed ID: 18930132
    [Abstract] [Full Text] [Related]

  • 16. Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.
    Aloisi G, Silvano E, Rossi M, Millan MJ, Maggio R.
    Neuropharmacology; 2011 Nov 26; 60(2-3):439-45. PubMed ID: 21035472
    [Abstract] [Full Text] [Related]

  • 17. Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates.
    Smith LA, Jackson MJ, Johnston L, Kuoppamaki M, Rose S, Al-Barghouthy G, Del Signore S, Jenner P.
    Clin Neuropharmacol; 2006 Nov 26; 29(3):112-25. PubMed ID: 16772809
    [Abstract] [Full Text] [Related]

  • 18. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R, Bardin L, Rodrigues M, Abrial E, Aliaga M, Newman-Tancredi A.
    Behav Pharmacol; 2009 Jul 26; 20(4):303-11. PubMed ID: 19584712
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists.
    Cook CD, Beardsley PM.
    Behav Pharmacol; 2004 Feb 26; 15(1):75-83. PubMed ID: 15075629
    [Abstract] [Full Text] [Related]

  • 20. Effect of methamphetamine on cognition and repetitive motor behavior of mice deficient for dopamine D2 and D3 receptors.
    Glickstein SB, Schmauss C.
    Ann N Y Acad Sci; 2004 Oct 26; 1025():110-8. PubMed ID: 15542707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.